In this Friday’s PCT Grand Rounds, investigators from the Suicide Prevention Outreach Trial (SPOT), an NIH Collaboratory Trial, will announce the study’s primary results.

Principal investigator Dr. Greg Simon and biostatistician Dr. Susan Shortreed, both of the Kaiser Permanente Washington Health Research Institute, will present “Population-Based Outreach to Prevent Suicidal Behavior: A Pragmatic Randomized Trial (SPOT NIH Collaboratory Trial).” The Grand Rounds session will be held on Friday, September 17, at 1:00 pm eastern. Join the online meeting.

The SPOT NIH Collaboratory Trial is a pragmatic clinical trial embedded in Mental Health Research Network sites to test suicide prevention strategies among adult patients who have serious thoughts of suicide. The trial tested 2 strategies: a collaborative care management approach for depression, and an online skills training method designed to help people manage painful emotions and stressful situations. Both strategies were compared with usual care.

SPOT is supported within the NIH Collaboratory by a cooperative agreement from the National Institute of Mental Health.